“The two companies began working together in November 2021 and initially signed a two-year licence agreement. Based on PromarkerD’s success, both parties wanted to extend the relationship and negotiated an additional five-year term. The updated distribution agreement provides Apacor with the exclusive right to sell the immunoassay version of the PromarkerD test in England, Scotland and Wales.“
“Proteomics and Apacor have also entered into discussions for extending their relationship into selected countries in continental Europe. The PromarkerD test is already CE Mark registered in the European Union, which is the EU’s mandatory conformity marking for goods sold within the Union.“
Article: Proteomics inks five-year extension to British distribution agreement
